Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
J Chin Med Assoc. 2012 Jun;75(6):275-80. doi: 10.1016/j.jcma.2012.03.002. Epub 2012 Apr 30.

Prevalence of hepatitis B and hepatitis C in patients with chronic schizophrenia living in institutions.

Author information

  • 1Department of Psychiatry, Taichung Veterans General Hospital, Taichung, Taiwan, ROC.

Abstract

BACKGROUND:

Preventing and managing hepatitis B virus (HBV) and hepatitis C virus (HCV) infection is an important public health issue worldwide, and Taiwan is one of the countries where viral hepatitis is most endemic. Previous studies have shown that patients with serious mental illnesses have a higher risk for hepatitis infection. We investigated the prevalence of HBV and HCV among institutionalized patients with chronic schizophrenia in Taiwan.

METHODS:

A total of 590 patients were recruited into the study. HBV surface antigen, HCV antibody, and liver function were determined for all participants.

RESULTS:

The seroprevalence of HBV surface antigen was 10.4% (males 12.6%, females 7.0%), and that of anti-HCV was 1.9% (males 2.6%, females 0.8%).

CONCLUSION:

Our study showed that the prevalences of HBV and HCV among institutionalized patients with chronic schizophrenia were no higher than the prevalences in the general population in Taiwan. The commodious environment and medical resources of the hospital where the patients were living might have prevented an elevation of HBV and HCV infection in those with schizophrenia, supplementing the continuing benefits from the HBV vaccination that was introduced in 1984.

Copyright © 2012. Published by Elsevier B.V.

PMID:
22721622
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Write to the Help Desk